Literature DB >> 20236082

Antibiotics in endophthalmitis: microbiological and pharmacokinetic considerations.

Carmen López-Cabezas1, Dolors Soy Muner, Merce Roca Massa, Josep M Mensa Pueyo.   

Abstract

Ocular infections must be treated with active antibiotics which could be administered by different routes: topical, systemic or intravitreal. In the case of endophthalmitis, the most important factor to avoid permanent damage of retina is an early antibiotic onset. Topical application of these drugs would be ineffective in the treatment of endophthalmitis, because of their poor penetration into the ocular globe. Systemic and intravitreal route of administration are the preferred in this setting, although for hydrophilic antibiotics, such as aminoglycosides, beta-lactams and glycopeptides, diffusion from plasma to vitreous cavity is not high enough to assure clinical efficacy. Intravitreal injection should be the favourite route of administration in this case. Ocular penetration of linezolid and fluorquinolones after systemic administration is excellent; hence intravitreal injections for these agents are not needed to achieve therapeutic concentrations at the vitreous cavity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20236082     DOI: 10.2174/157488410790410597

Source DB:  PubMed          Journal:  Curr Clin Pharmacol        ISSN: 1574-8847


  11 in total

1.  Microbial profile and antibiotic susceptibility of culture-positive bacterial endophthalmitis.

Authors:  L Pagani
Journal:  Eye (Lond)       Date:  2011-07-01       Impact factor: 3.775

2.  Poor prognostic factors in post-traumatic endophthalmitis following open globe injury.

Authors:  Sukhum Silpa-Archa; Akkaranisorn Dejkong; Kwanchanoke Kumsiang; Peranut Chotcomwongse; Janine M Preble; C Stephen Foster
Journal:  Int J Ophthalmol       Date:  2020-12-18       Impact factor: 1.779

Review 3.  Modeling intraocular bacterial infections.

Authors:  Roger A Astley; Phillip S Coburn; Salai Madhumathi Parkunan; Michelle C Callegan
Journal:  Prog Retin Eye Res       Date:  2016-05-03       Impact factor: 21.198

4.  Staphylococcus aureus infection of the optic nerve.

Authors:  Senad Osmanovic; Omar M Al-Heeti; Amy Y Lin; Sean P Zivin; Julie Ann Justo; Stockton M Mayer; Vinay K Aakalu; Heather E Moss; Mahesh C Patel
Journal:  J Neuroophthalmol       Date:  2015-03       Impact factor: 3.042

5.  Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes.

Authors:  D A M Lyall; A Tey; B Foot; S T D Roxburgh; M Virdi; C Robertson; C J MacEwen
Journal:  Eye (Lond)       Date:  2012-10-12       Impact factor: 3.775

Review 6.  Role of intravitreal/intracameral antibiotics to prevent traumatic endophthalmitis - Meta-analysis.

Authors:  Thanigasalam Thevi; Adinegara Lutfi Abas
Journal:  Indian J Ophthalmol       Date:  2017-10       Impact factor: 1.848

Review 7.  Review of Intraocular Pharmacokinetics of Anti-Infectives Commonly Used in the Treatment of Infectious Endophthalmitis.

Authors:  Andrea Luaces-Rodríguez; Miguel González-Barcia; María José Blanco-Teijeiro; María Gil-Martínez; Francisco Gonzalez; Francisco Gómez-Ulla; María-Jesús Lamas; Francisco-Javier Otero-Espinar; Anxo Fernández-Ferreiro
Journal:  Pharmaceutics       Date:  2018-05-29       Impact factor: 6.321

8.  Intravenous administration of Penicillin results in therapeutic intravitreal levels in chronic postoperative endophthalmitis.

Authors:  Chloe Thabet; Chloe C C Gottlieb; Bernard R Hurley; Guijun Zhang; Adeel Sherazi; Jonathan B Angel
Journal:  J Ophthalmic Inflamm Infect       Date:  2021-01-22

9.  Infectious endophthalmitis: review of 420 cases.

Authors:  Chavakij Bhoomibunchoo; Tanapat Ratanapakorn; Suthasinee Sinawat; Thuss Sanguansak; Kittipatra Moontawee; Yosanan Yospaiboon
Journal:  Clin Ophthalmol       Date:  2013-02-01

10.  Factors affecting visual outcomes after treatment of infectious endophthalmitis in northeastern Thailand.

Authors:  Yosanan Yospaiboon; Anocha Intarapanich; Wipada Laovirojjanakul; Tanapat Ratanapakorn; Suthasinee Sinawat; Thuss Sanguansak; Chavakij Bhoomibunchoo
Journal:  Clin Ophthalmol       Date:  2018-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.